Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis

Olivia R. Mitchel, Chiu-Hsieh (Paul) Hsu, Leah S. Millheiser, Irene L. Wapnir, Shreya Chandak, Missy Tran, Jennifer Erdrich · 2026

Read Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis by Olivia R. Mitchel, Chiu-Hsieh (Paul) Hsu, Leah S. Millheiser, Irene L. Wapnir, Shreya Chandak, Missy Tran, Jennifer Erdrich (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526394.txt.

Description

Olivia R. Mitchel and others analyze, in a 2026 registry study, survival among older breast cancer survivors who used vaginal estrogen, a treatment for genitourinary menopause symptoms that hormone therapy often worsens. Whether local estrogen is safe after breast cancer has been debated, and guidance varies, holding back a helpful therapy.

The retrospective cohort used a linked cancer registry and survey program with 25,874 women aged 65 or older diagnosed between 2007 and 2017. About one thousand had used vaginal estrogen after their cancer was found. Simple models linked use with lower overall and cancer-specific death. When use was modeled as changing over time, those links faded to nonsignificance, a sign that immortal time or selection bias explained them. The authors conclude local estrogen showed no survival harm.

Catalog record

CREATOROlivia R. Mitchel, Chiu-Hsieh (Paul) Hsu, Leah S. Millheiser, Irene L. Wapnir, Shreya Chandak, Missy Tran, Jennifer Erdrich
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25164
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13526394

Browse the full library · About the Tower of Babel